文献速递儿童青少年精神

儿童青少年神经发育障碍候选诊断生物标志物系统综述

Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review.
PubMed 文献 · World Psychiatry · 2023-01-01

未发现任何生物标志物在至少两项独立研究中显示敏感性和特异性均≥80%,现有研究多存在样本量小、方法异质等局限。

要点

  • 未发现满足两项独立研究、敏感性及特异性均≥80%的候选生物标志物。
  • 阳性预测值和阴性预测值等效度指标在研究中很少报告。
  • 现有研究局限包括样本量小、方法异质、聚焦单一而非联合标志物等。

核心结论

  • 目前没有候选诊断生物标志物在至少两项独立研究中显示敏感性和特异性均≥80%。

研究设计与样本

  • 系统检索Medline和Embase及Embase Classic至2022年4月6日,并补充检索GWAS及国际联盟的神经影像或神经生理研究。

主要发现

  • 多数研究仅关注关联,未发现满足两项独立研究同向且敏感性、特异性均≥80%的生物标志物。
  • 阳性预测值和阴性预测值等效度指标报告少见。

关键数值与推荐

  • 候选生物标志物为有前景的定义:至少两项独立研究提供敏感性和特异性均≥80%的证据。

临床怎么用

  • 未来需采用多变量和多层次方法寻找候选生物标志物,并在外部独立样本中验证,再评估可行性和成本效益后方可临床使用。

局限性

  • 现有研究多存在样本量小、方法异质、候选标志物目标异质、过度聚焦单一而非联合标志物特征、对潜在混杂因素考虑不完整等局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neurodevelopmental disorders - including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, communication disorders, intellectual disability, motor disorders, specific learning disorders, and tic disorders - manifest themselves early in development. Valid, reliable and broadly usable biomarkers supporting a timely diagnosis of these disorders would be highly relevant from a clinical and public health standpoint. We conducted the first systematic review of studies on candidate diagnostic biomarkers for these disorders in children and adolescents. We searched Medline and Embase + Embase Classic with terms relating to biomarkers until April 6, 2022, and conducted additional targeted searches for genome-wide association studies (GWAS) and neuroimaging or neurophysiological studies carried out by international consortia. We considered a candidate biomarker as promising if it was reported in at least two independent studies providing evidence of sensitivity and specificity of at least 80%. After screening 10,625 references, we retained 780 studies (374 biochemical, 203 neuroimaging, 133 neurophysiological and 65 neuropsychological studies, and five GWAS), including a total of approximately 120,000 cases and 176,000 controls. While the majority of the studies focused simply on associations, we could not find any biomarker for which there was evidence - from two or more studies from independent research groups, with results going into the same direction - of specificity and sensitivity of at least 80%. Other important metrics to assess the validity of a candidate biomarker, such as positive predictive value and negative predictive value, were infrequently reported. Limitations of the currently available studies include mostly small sample size, heterogeneous approaches and candidate biomarker targets, undue focus on single instead of joint biomarker signatures, and incomplete accounting for potential confounding factors. Future multivariable and multi-level approaches may be best suited to find valid candidate biomarkers, which will then need to be validated in external, independent samples and then, importantly, tested in terms of feasibility and cost-effectiveness, before they can be implemented in daily clinical practice.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cortese S, Solmi M, Michelini G, et al. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review. World Psychiatry. 2023. PMID: 36640395. doi:10.1002/wps.21037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。